Clinical Features and Prognostic Factors in Anti-Myelin Oligodendrocyte Glycoprotein Antibody Positive Optic Neuritis

References

• Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177–189. doi:10.1212/WNL.0000000000001729.
   PubMed Web of Science ®Google Scholar
• Jarius S, Ruprecht K, Kleiter I, et al. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflammation. 2016;13(1):280. doi:10.1186/s12974-016-0718-0.
   PubMed Web of Science ®Google Scholar
• Ishikawa H, Kezuka T, Shikishima K, et al. Epidemiologic and clinical characteristics of optic neuritis in Japan. Ophthalmology. 2019;126(10):1385–1398. doi:10.1016/j.ophtha.2019.04.042.
   PubMed Web of Science ®Google Scholar
• Ko J, Na JH, Lee H, Byun JC, Kim JS, Lee YM. A case of myelin oligodendrocyte glycoprotein antibody-associated disease with acute bilateral total blindness. Ann Child Neurol. 2022;30(4):197–200. doi:10.26815/acn.2022.00143.
   Google Scholar
• Petzold A, Fraser CL, Abegg M, et al. Diagnosis and classification of optic neuritis. Lancet Neurol. 2022;21(12):1120–1134. doi:10.1016/S1474-4422(22)00200-9.
   PubMed Web of Science ®Google Scholar
• Banwell B, Bennett JL, Marignier R, et al. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol. 2023;22(3):268–282. doi:10.1016/S1474-4422(22)00431-8.
   PubMed Web of Science ®Google Scholar
• Lange C, Feltgen N, Junker B, Schulze-Bonsel K, Bach M. Resolving the clinical acuity categories “hand motion” and “counting fingers” using the Freiburg visual acuity test (FrACT). Graefes Arch Clin Exp Ophthalmol. 2009;247(1):137–142. doi:10.1007/s00417-008-0926-0.
   PubMed Web of Science ®Google Scholar
• Akaishi T, Nakashima I, Takeshita T, et al. Lesion length of optic neuritis impacts visual prognosis in neuromyelitis optica. J Neuroimmunol. 2016;293:28–33.
   PubMed Web of Science ®Google Scholar
• Chen JJ, Flanagan EP, Jitprapaikulsan J, et al. Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis: clinical characteristics, radiologic clues, and outcome. Am J Ophthalmol. 2018;195:8–15.
   PubMed Web of Science ®Google Scholar
• Kim SM, Woodhall MR, Kim JS, et al. Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS. Neurology. 2015;2(6). doi:10.1212/NXI.0000000000000163.
   Google Scholar
• Moon Y, Lim BC, Chae JH, Jung JH. Clinical characteristics and clinical course of myelin oligodendrocyte glycoprotein antibody-seropositive pediatric optic neuritis. Mult Scler Relat Disord. 2022;60:103709.
   PubMed Web of Science ®Google Scholar
• Sechi E, Cacciaguerra L, Chen JJ, et al. Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management. Front Neurol. 2022;13:885218.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Tan S, Chan TCY, et al. Clinical features of demyelinating optic neuritis with seropositive myelin oligodendrocyte glycoprotein antibody in Chinese patients. Br J Ophthalmol. 2018;102(10):1372–1377. doi:10.1136/bjophthalmol-2017-311177.
   PubMed Web of Science ®Google Scholar
• Kang H, Qiu H, Hu X, Wei S, Tao Y. Differences in neuropathic pain and radiological features between AQP4-ON, MOG-ON, and IDON. Front Pain Res (Lausanne). 2022;3:870211.
   PubMedGoogle Scholar
• Denis M, Woillez JP, Smirnov VM, et al. Optic nerve lesion length at the acute phase of optic neuritis is predictive of retinal neuronal loss. Neurology. 2022;9(2). doi:10.1212/NXI.0000000000001135.
   Web of Science ®Google Scholar
• Akaishi T, Nakashima I, Takeshita T, et al. Different etiologies and prognoses of optic neuritis in demyelinating diseases. J Neuroimmunol. 2016;299:152–157.
   PubMed Web of Science ®Google Scholar
• Dubey D, Pittock SJ, Krecke KN, et al. Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody. JAMA Neurol. 2019;76(3):301–309. doi:10.1001/jamaneurol.2018.4053.
   PubMed Web of Science ®Google Scholar
• Akaishi T, Misu T, Takahashi T, et al. Progression pattern of neurological disability with respect to clinical attacks in anti-MOG antibody-associated disorders. J Neuroimmunol. 2021;351:577467.
   PubMed Web of Science ®Google Scholar
• Matsumoto Y, Mori S, Ueda K, et al. Impact of the anti-aquaporin-4 autoantibody on inner retinal structure, function and structure-function associations in Japanese patients with optic neuritis. PLoS One. 2017;12(2):e0171880. doi:10.1371/journal.pone.0171880.
   PubMed Web of Science ®Google Scholar
• Matsuda R, Kezuka T, Umazume A, Okunuki Y, Goto H, Tanaka K. Clinical profile of anti-myelin oligodendrocyte glycoprotein antibody seropositive cases of optic neuritis. Neuroophthalmology. 2015;39:213–219.
   PubMed Web of Science ®Google Scholar
• Ueda K, Kanamori A, Akashi A, Tomioka M, Kawaka Y, Nakamura M. Effects of axial length and age on circumpapillary retinal nerve fiber layer and inner macular parameters measured by 3 types of SD-OCT instruments. J Glaucoma. 2016;25:383–389.
   PubMed Web of Science ®Google Scholar